Infective Endocarditis and Antimicrobial Timing: A Case for Delay? - Takeaways - MDSpire

Infective Endocarditis and Antimicrobial Timing: A Case for Delay?

  • By

  • Elisavet Stavropoulou

  • Bruno Ledergerber

  • Nicolas Fourré

  • Virgile Zimmermann

  • Jana Epprecht

  • Nicoleta Ianculescu

  • Pierre Monney

  • Georgios Tzimas

  • Michelle Frank

  • Laurence Senn

  • Lars Niclauss

  • Matthias Kirsch

  • Mathias Van Hemelrijck

  • Omer Dzemali

  • Benoit Guery

  • Barbara Hasse

  • Matthaios Papadimitriou-Olivgeris

  • October 7, 2025

  • 0 min

Share

  • 1

    Current guidelines recommend prompt initiation of antimicrobial treatment after obtaining blood cultures in suspected infective endocarditis (IE).

  • 2

    This study assessed the impact of deferring antimicrobial treatment in clinically stable patients with suspected IE across two Swiss hospitals.

  • 3

    Among 1230 episodes, 30-day mortality was 5% with no significant difference between immediate and deferred treatment groups.

  • 4

    The composite primary endpoint of new embolic events or infections also showed no significant difference between immediate and deferred treatment.

  • 5

    Deferring antimicrobial treatment until blood culture results in clinically stable patients with suspected IE did not worsen clinical outcomes.

Original Source(s)

Related Content